Clinical Trial Brings Hope for Prurigo Nodularis Patients

Serlopitant is the first treatment shown to be effective for patients with this uncommon disorder, which is characterized by crusty lesions and intense itch.
Medscape Medical News

http://ift.tt/2mPyrx0